bioAffinity Technologies Income Statement (2022-2025) | BIAF

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -1.15M0.00M0.00M921.000.02M0.30M2.21M2.41M2.40M2.35M2.21M1.85M1.27M1.45M
Cost of Revenue 146.00175.0087.000.00M0.07M1.66M1.57M1.41M1.44M1.56M1.37M1.02M0.94M
Gross Profit 0.00M0.00M834.000.02M0.22M0.55M0.83M0.99M0.91M0.65M0.49M0.25M0.50M
Operating items
Depreciation & Amortization - Total 800.000.01M0.02M0.02M0.05M0.17M0.04M0.04M0.04M0.04M0.04M0.04M0.04M
Research & Development 0.28M0.25M0.32M0.45M0.37M0.34M0.33M0.43M0.39M0.40M0.27M0.39M0.37M0.31M0.33M
Selling, General & Administrative 0.39M0.41M0.60M1.19M1.15M1.40M2.02M2.21M2.19M2.47M2.36M2.92M2.45M2.21M2.21M
Other Operating Expenses 0.05M0.03M0.06M-0.02M0.02M0.04M0.19M1.74M1.73M1.57M1.64M1.80M1.62M1.21M1.15M
Operating Expenses 0.73M0.69M0.98M1.63M1.56M1.80M2.59M4.56M4.35M4.49M4.32M5.15M4.48M3.79M3.74M
Operating Income -0.73M-0.68M-0.98M-1.62M-1.56M-1.78M-2.29M-2.34M-1.95M-2.09M-1.97M-2.95M-2.63M-2.52M-2.29M
EBIT -0.73M-0.68M-0.98M-1.62M-1.56M-1.78M-2.29M-2.34M-1.95M-2.09M-1.97M-2.95M-2.63M-2.52M-2.29M
Non-operating items
Interest & Investment Income 571.000.01M0.04M0.04M0.04M0.03M0.01M0.01M0.01M0.00M0.00M542.000.00M0.00M
Other Non Operating Income 0.00M-0.00M0.00M1.000.01M640.002.000.04M513.00
Non Operating Income -1.15M0.04M0.04M0.01M-0.03M-0.01M-0.02M-0.02M-0.02M-0.02M-1.52M-2.76M
Net income details
EBT -1.47M-0.09M-4.92M-1.67M-1.52M-1.74M-2.29M-2.37M-1.96M-2.10M-2.00M-2.97M-2.65M-4.03M-5.05M
Tax Provisions 0.00M300.00-1.000.01M0.00M0.00M0.00M0.00M0.01M0.00M0.01M0.03M0.00M
Profit After Tax -1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M
Income from Continuing Operations -1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M
Consolidated Net Income -1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M
Income towards Parent Company -1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M
Net Income towards Common Stockholders -1.47M-0.09M-4.92M-1.67M-1.53M-1.74M-2.29M-2.37M-1.96M-2.11M-2.00M-2.97M-2.66M-4.06M-5.05M
Additional items
EPS (Basic) -0.55-0.03-1.170.22-0.18-0.20-0.26-0.26-0.20-0.19-4.8415.47-0.16-0.17-4.74
EPS (Weighted Average and Diluted) -0.55-1.170.22-0.18-0.20-0.26-0.26-0.20-0.19-4.8415.47-0.16-0.17-4.74
Shares Outstanding (Weighted Average) 0.14M0.28M0.28M0.28M0.28M0.28M0.31M0.32M0.32M0.39M0.51M0.52M0.61M0.91M0.95M
Shares Outstanding (Diluted Average) 2.69M4.20M4.50M8.43M8.52M8.70M8.75M9.92M11.39M0.41M12.13M16.26M24.02M1.07M
EBITDA -0.73M-0.68M-0.98M-1.62M-1.54M-1.76M-2.25M-2.18M-1.91M-2.05M-1.93M-2.90M-2.58M-2.47M-2.25M
Interest Expenses 1.15M0.90M0.09M0.00M0.00M0.02M0.02M0.02M0.02M0.02M0.03M0.02M0.48M0.01M
Tax Rate 0.00%